These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The preventative effects of vasodilating beta-blockers in cardiovascular disease. Raftery EB Eur Heart J; 1996 Apr; 17 Suppl B():30-8. PubMed ID: 8733069 [TBL] [Abstract][Full Text] [Related]
4. Carvedilol versus verapamil in chronic stable angina: a multicentre trial. Hauf-Zachariou U; Blackwood RA; Gunawardena KA; O'Donnell JG; Garnham S; Pfarr E Eur J Clin Pharmacol; 1997; 52(2):95-100. PubMed ID: 9174677 [TBL] [Abstract][Full Text] [Related]
5. [Complex ventricular arrhythmias and carvedilol: efficacy in hemodialyzed uremic patients]. Cice G; Tagliamonte E; Ferrara L; Di Benedetto A; Iacono A Cardiologia; 1998 Jun; 43(6):597-604. PubMed ID: 9675959 [TBL] [Abstract][Full Text] [Related]
6. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S; Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332 [TBL] [Abstract][Full Text] [Related]
7. Value of carvedilol in congestive heart failure secondary to coronary artery disease. Das Gupta P; Broadhurst P; Raftery EB; Lahiri A Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300 [TBL] [Abstract][Full Text] [Related]
8. Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure. Akdeniz B; Guneri S; Savas IZ; Aslan O; Baris N; Badak O; Kirimli O; Göldeli O Int Heart J; 2006 Jul; 47(4):565-73. PubMed ID: 16960411 [TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Krum H; Sackner-Bernstein JD; Goldsmith RL; Kukin ML; Schwartz B; Penn J; Medina N; Yushak M; Horn E; Katz SD Circulation; 1995 Sep; 92(6):1499-506. PubMed ID: 7664433 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a new vasodilating beta-blocking agent, carvedilol, in exertional angina using holter monitoring. Kishida H; Saito T; Fukuma N; Hata N; Suzuki T; Ohtsu F Jpn Heart J; 1990 Jul; 31(4):449-60. PubMed ID: 1977939 [TBL] [Abstract][Full Text] [Related]
11. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure. Mortara A; La Rovere MT; Pinna GD; Maestri R; Capomolla S; Cobelli F J Am Coll Cardiol; 2000 Nov; 36(5):1612-8. PubMed ID: 11079666 [TBL] [Abstract][Full Text] [Related]
12. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure. DasGupta P; Broadhurst P; Lahiri A J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S12-6. PubMed ID: 1721973 [TBL] [Abstract][Full Text] [Related]
13. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653 [TBL] [Abstract][Full Text] [Related]
14. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. McTavish D; Campoli-Richards D; Sorkin EM Drugs; 1993 Feb; 45(2):232-58. PubMed ID: 7681374 [TBL] [Abstract][Full Text] [Related]
15. Effects of carvedilol on heart rate dynamics in patients with congestive heart failure. Ridha M; Mäkikallio TH; Lopera G; Pastor J; de Marchena E; Chakko S; Huikuri HV; Castellanos A; Myerburg RJ Ann Noninvasive Electrocardiol; 2002 Apr; 7(2):133-8. PubMed ID: 12049685 [TBL] [Abstract][Full Text] [Related]
16. The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure. Yildirir A; Sade E; Tokgozoglu L; Oto A Eur J Heart Fail; 2001 Dec; 3(6):717-21. PubMed ID: 11738224 [TBL] [Abstract][Full Text] [Related]
17. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function. Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827 [TBL] [Abstract][Full Text] [Related]
18. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140 [TBL] [Abstract][Full Text] [Related]
19. Carvedilol: a review of its use in chronic heart failure. Keating GM; Jarvis B Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089 [TBL] [Abstract][Full Text] [Related]
20. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]